FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005508478> ?p ?o ?g. }

• W2005508478 endingPage "695" @default.
• W2005508478 startingPage "688" @default.
• W2005508478 abstract "Immunofluorescence stainings for the CD10 antigen and terminal deoxynucleotidyl transferase (TdT) can be used for the detection of leukemic blasts in CD10+ precursor-B-acute lymphoblastic leukemia (precursor-B-ALL) patients, but can also provide insight into the regeneration of normal precursor-B-cells in bone marrow (BM). Over a period of 15 years, we studied the regeneration of CD10+, TdT+, and CD10+/TdT+ cells in BM of children with (CD10+) precursor-B-ALL during and after treatment according to three different treatment protocols of the Dutch Childhood Leukemia Study Group (DCLSG) which differed both in medication and time schedule. This study included a total of 634 BM samples from 46 patients who remained in continuous complete remission (CCR) after treatment according to DCLSG protocols VI (1984–1988; n = 8), VII (1988–1991; n = 10) and VIII (1991–1997; n = 28). After the cytomorphologically defined state of complete remission with CD10+ and CD10+/TdT+ frequencies generally below 1% of total BM cells, a 10-fold increase in precursor-B-cells was observed in protocol VII and protocol VIII, but not in protocol VI. At first sight this precursor-B-cell regeneration during treatment resembled the massive regeneration of the precursor-B-cell compartment after maintenance treatment, and appeared to be related to the post-induction or post-central nervous system (CNS) therapy stops in protocols VII and VIII. However, careful evaluation of the distribution between the ‘more mature’ (CD10+/TdT−) and the ‘immature’ (CD10+/TdT+) precursor-B-cells revealed major differences between the post-induction/post-re-induction precursor-B-cell regeneration (low ‘mature/immature’ ratio: generally <1.0), the post-cns treatment regeneration (moderate ‘mature/immature’ ratio: 1.2–2.8), and the post-maintenance regeneration (high ‘mature/ immature’ ratio: 5.7–7.6). we conclude that a therapy stop of approximately 2 weeks is already sufficient to induce significant precursor-b-cell regeneration even from aplastic bm after induction treatment. moreover, differences in precursor-b-cell regeneration patterns are related to the intensity of the preceding treatment block, with lower ‘mature/immature’ ratios after the highly intensive treatment blocks. this information is essential for a correct interpretation of flow cytometric immunophenotyping results of bm samples during follow-up of leukemia patients. particularly in precursor-b-all patients, regeneration of normal precursor-b-cells should not be mistaken for a relapse." @default.
• W2005508478 created "2016-06-24" @default.
• W2005508478 creator A5006790084 @default.
• W2005508478 creator A5012102884 @default.
• W2005508478 creator A5014048325 @default.
• W2005508478 creator A5016157842 @default.
• W2005508478 creator A5052462856 @default.
• W2005508478 creator A5086054141 @default.
• W2005508478 date "2000-04-01" @default.
• W2005508478 modified "2023-10-13" @default.
• W2005508478 title "Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy" @default.
• W2005508478 cites W1489279917 @default.
• W2005508478 cites W1579241132 @default.
• W2005508478 cites W1925805959 @default.
• W2005508478 cites W1973476943 @default.
• W2005508478 cites W1983900466 @default.
• W2005508478 cites W1989648826 @default.
• W2005508478 cites W2003346908 @default.
• W2005508478 cites W2020206419 @default.
• W2005508478 cites W2021567384 @default.
• W2005508478 cites W2022748292 @default.
• W2005508478 cites W2025647017 @default.
• W2005508478 cites W2041816963 @default.
• W2005508478 cites W2077146310 @default.
• W2005508478 cites W2085189167 @default.
• W2005508478 cites W2130138579 @default.
• W2005508478 cites W2147996630 @default.
• W2005508478 cites W2162305228 @default.
• W2005508478 cites W2285719605 @default.
• W2005508478 cites W339316500 @default.
• W2005508478 cites W4242108431 @default.
• W2005508478 doi "https://doi.org/10.1038/sj.leu.2401749" @default.
• W2005508478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10764156" @default.
• W2005508478 hasPublicationYear "2000" @default.
• W2005508478 type Work @default.
• W2005508478 sameAs 2005508478 @default.
• W2005508478 citedByCount "72" @default.
• W2005508478 countsByYear W20055084782012 @default.
• W2005508478 countsByYear W20055084782013 @default.
• W2005508478 countsByYear W20055084782014 @default.
• W2005508478 countsByYear W20055084782015 @default.
• W2005508478 countsByYear W20055084782016 @default.
• W2005508478 countsByYear W20055084782017 @default.
• W2005508478 countsByYear W20055084782018 @default.
• W2005508478 countsByYear W20055084782019 @default.
• W2005508478 countsByYear W20055084782020 @default.
• W2005508478 countsByYear W20055084782021 @default.
• W2005508478 countsByYear W20055084782022 @default.
• W2005508478 crossrefType "journal-article" @default.
• W2005508478 hasAuthorship W2005508478A5006790084 @default.
• W2005508478 hasAuthorship W2005508478A5012102884 @default.
• W2005508478 hasAuthorship W2005508478A5014048325 @default.
• W2005508478 hasAuthorship W2005508478A5016157842 @default.
• W2005508478 hasAuthorship W2005508478A5052462856 @default.
• W2005508478 hasAuthorship W2005508478A5086054141 @default.
• W2005508478 hasBestOaLocation W20055084781 @default.
• W2005508478 hasConcept C124964019 @default.
• W2005508478 hasConcept C126322002 @default.
• W2005508478 hasConcept C142724271 @default.
• W2005508478 hasConcept C1491633281 @default.
• W2005508478 hasConcept C153911025 @default.
• W2005508478 hasConcept C154113507 @default.
• W2005508478 hasConcept C196795494 @default.
• W2005508478 hasConcept C203014093 @default.
• W2005508478 hasConcept C204232928 @default.
• W2005508478 hasConcept C2776694085 @default.
• W2005508478 hasConcept C2778461978 @default.
• W2005508478 hasConcept C2778904437 @default.
• W2005508478 hasConcept C2780007613 @default.
• W2005508478 hasConcept C2781107101 @default.
• W2005508478 hasConcept C2909962599 @default.
• W2005508478 hasConcept C55493867 @default.
• W2005508478 hasConcept C71924100 @default.
• W2005508478 hasConcept C86803240 @default.
• W2005508478 hasConceptScore W2005508478C124964019 @default.
• W2005508478 hasConceptScore W2005508478C126322002 @default.
• W2005508478 hasConceptScore W2005508478C142724271 @default.
• W2005508478 hasConceptScore W2005508478C1491633281 @default.
• W2005508478 hasConceptScore W2005508478C153911025 @default.
• W2005508478 hasConceptScore W2005508478C154113507 @default.
• W2005508478 hasConceptScore W2005508478C196795494 @default.
• W2005508478 hasConceptScore W2005508478C203014093 @default.
• W2005508478 hasConceptScore W2005508478C204232928 @default.
• W2005508478 hasConceptScore W2005508478C2776694085 @default.
• W2005508478 hasConceptScore W2005508478C2778461978 @default.
• W2005508478 hasConceptScore W2005508478C2778904437 @default.
• W2005508478 hasConceptScore W2005508478C2780007613 @default.
• W2005508478 hasConceptScore W2005508478C2781107101 @default.
• W2005508478 hasConceptScore W2005508478C2909962599 @default.
• W2005508478 hasConceptScore W2005508478C55493867 @default.
• W2005508478 hasConceptScore W2005508478C71924100 @default.
• W2005508478 hasConceptScore W2005508478C86803240 @default.
• W2005508478 hasIssue "4" @default.
• W2005508478 hasLocation W20055084781 @default.
• W2005508478 hasLocation W20055084782 @default.
• W2005508478 hasOpenAccess W2005508478 @default.
• W2005508478 hasPrimaryLocation W20055084781 @default.
• W2005508478 hasRelatedWork W1932229465 @default.

• next